Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Application of continuous flow electrophoresis to the study of the blood coagulation proteins and the fibrinolytic enzyme system. I. Normal human materials.

× No keyword cloud information.

11 in total

1. Differential diagnosis and treatment in hemorrhagic disease.

Authors: J H LEWIS; P DIDISHEIM
Journal: AMA Arch Intern Med Date: 1957-07

2. Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency.

Authors: C HOUGIE; E M BARROW; J B GRAHAM
Journal: J Clin Invest Date: 1957-03 Impact factor: 14.808

3. Application of paper electrophoresis to separation of blood-clotting factors.

Authors: C A OWEN; B F McKENZIE
Journal: J Appl Physiol Date: 1954-05 Impact factor: 3.531

4. [Separation of drug mixtures on filter paper by electric field deflection].

Authors: W GRASSMANN; K HANNING
Journal: Hoppe Seylers Z Physiol Chem Date: 1953

5. An activator system in blood indispensable for formation of plasmin by streptokinase.

Authors: S MULLERTZ; M LASSEN
Journal: Proc Soc Exp Biol Med Date: 1953-02

6. Prothrombin and accessory factors; clinical significance.

Authors: P A OWREN
Journal: Am J Med Date: 1953-02 Impact factor: 4.965

7. Studies on a proteolytic enzyme system of the blood. Activation of profibrinolysin by serum fibrinolysokinase.

Authors: J H LEWIS; J H FERGUSON
Journal: Proc Soc Exp Biol Med Date: 1951-10

8. Congenital SPCA deficiency: a hitherto unrecognized coagulation defect with hemorrhage rectified by serum and serum fractions.

Authors: B ALEXANDER; R GOLDSTEIN; G LANDWEHR; C D COOK
Journal: J Clin Invest Date: 1951-06 Impact factor: 14.808

9. Some properties of purified prothrombin and its activation with sodium citrate.

Authors: W H SEEGERS; R I McCLAUGHRY; J L FAHEY
Journal: Blood Date: 1950-05 Impact factor: 22.113

10. The prothrombin conversion accelerator of serum (SPCA): its partial purification and its properties compared with serum AC-globulin.

Authors: B ALEXANDER; R GOLDSTEIN; G LANDWEHR
Journal: J Clin Invest Date: 1950-07 Impact factor: 14.808

8 in total

1. THE INDUCTION OF PERMEABILITY-INCREASING ACTIVITY IN HUMAN PLASMA BY ACTIVATED HAGEMAN FACTOR.

Authors: O D RATNOFF; A A MILES
Journal: Br J Exp Pathol Date: 1964-06

2. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent.

Authors: O D RATNOFF; E W DAVIE; D L MALLETT
Journal: J Clin Invest Date: 1961-05 Impact factor: 14.808

3. Thromboplastin generation accelerator, a newly recognized component of the blood coagulation mechanism present in excess in certain thrombotic states.

Authors: C A PASCUZZI; J A SPITTEL; J H THOMPSON; C A OWEN
Journal: J Clin Invest Date: 1961-06 Impact factor: 14.808

4. Application of continuous flow electrophoresis to the study of the blood coagulation proteins. II. The hemophilias (A and B).

Authors: J H LEWIS; W R MERCHANT
Journal: J Clin Invest Date: 1959-11 Impact factor: 14.808

Application of continuous flow electrophoresis to the study of the blood coagulation proteins and the fibrinolytic enzyme system. I. Normal human materials.